OmniAb (OABI) Other Non-Current Liabilities (2021 - 2026)

OmniAb (OABI) reported Other Non-Current Liabilities of $75000.0 for Q1 2026, down 14.77% year-over-year from $88000.0 in Q1 2025, and down 3.85% quarter-over-quarter from $78000.0 in Q4 2025.

OmniAb (OABI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Other Non-Current Liabilities data on file, last reported at $75000.0 in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $75000.0, down 14.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $75000.0 (down 14.77% YoY), and the FY2025 annual result was $78000.0, down 9.3% from the prior year.
  • Other Non-Current Liabilities eased to $75000.0 in Q1 2026 per OABI's latest filing, from $78000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $3.5 million in Q3 2023 and troughed at $31000.0 in Q1 2024.
  • A 5-year average of $885071.4 and a median of $82000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities sank 99.05% in 2022, then surged 6863.04% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $46000.0 in 2022, then surged by 6863.04% to $3.2 million in 2023, then sank by 97.32% to $86000.0 in 2024, then fell by 9.3% to $78000.0 in 2025, then retreated by 3.85% to $75000.0 in 2026.
  • Business Quant data shows OABI's Other Non-Current Liabilities at $75000.0 in Q1 2026, $78000.0 in Q4 2025, and $516000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 75,000.00
Dec 31, 2025 78,000.00
Sep 30, 2025 516,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 88,000.00
Dec 31, 2024 86,000.00
Sep 30, 2024 53,000.00
Jun 30, 2024 1.19 Mn
Mar 31, 2024 31,000.00
Dec 31, 2023 3.20 Mn
Sep 30, 2023 3.52 Mn
Jun 30, 2023 3.38 Mn
Mar 31, 2023 44,000.00
Dec 31, 2022 46,000.00
Dec 31, 2021 4.83 Mn